Caspofungin salvage therapy in Pneumocystis jirovecii pneumonia.
暂无分享，去创建一个
Wen-Sen Lee | P. Hsueh | S. Jean | Tai-Chin Hsieh | T. Ou | Fu-Lun Chen
[1] Wen-Sen Lee,et al. Successful salvage therapy with micafungin for Candida empyema thoracis. , 2015, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[2] Zhe Luo,et al. Combination of caspofungin and low‐dose trimethoprim/sulfamethoxazole for the treatment of severe Pneumocystis jirovecii pneumonia in renal transplant recipients , 2013, Nephrology.
[3] S. Choi,et al. Is caspofungin really an effective treatment for Pneumocystis jirovecii pneumonia in immunocompromised patients without human immunodeficiency virus infection? Experiences at a single center and a literature review , 2013, Scandinavian journal of infectious diseases.
[4] W. Ko,et al. Improved outcome of Pneumocystis pneumonia by early treatment. , 2012, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[5] Chang-Pan Liu,et al. Mortality predictors of Pneumocystis jirovecii pneumonia in human immunodeficiency virus-infected patients at presentation: Experience in a tertiary care hospital of northern Taiwan. , 2011, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[6] B. Gazzard,et al. A trial of caspofungin salvage treatment in PCP pneumonia , 2010, Thorax.